Role of transcription factors in the pathogenesis of pituitary adenomas: A review

Journal of Neuro-Oncology

Volumn 55, Issue 3, 2001, Pages 185-193

  Suhardja, A ^a   Kovacs, K ^b   Rutka, J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Genes; Molecular biology; Pathophysiology; Pituitary adenomas; Transcription factors

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GROWTH HORMONE RELEASING FACTOR; MYC PROTEIN; PROTEIN C FOS; PROTEIN INHIBITOR; PROTEIN P107; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PIT 1;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; DRUG MECHANISM; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; MOLECULAR BIOLOGY; NEUROENDOCRINE TUMOR; NONHUMAN; ONCOGENE; PATHOGENESIS; PATHOPHYSIOLOGY; PROLACTINOMA; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ADENOMA; AMINO ACID MOTIFS; BINDING SITES; DNA; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HUMANS; LEUCINE ZIPPERS; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 0035709145     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013819827162     Document Type: Article

References (77)

1. Molecular machines that control genes
2. Mechanism of transcriptional activation: Differences and similarity between yeast, drosophila and man
3. Transcription factor mutations and disease
4. Pax2 in development and renal disease
5. Surfing the p53 network
6. The retinoblastoma protein pathway in cell cycle control and cancer
7. Current concepts in neuro-oncology: The cell cycle - A review
8. Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis
9. Transcription factors in normal and neoplastic pituitary tissues
10. Transcriptional control of cell phenotypes in the neuroendocrine system
11. Transcription activation by recruitment
12. Transcription factors in development, growth, and aging
13. Transcription factors: Structural families and principles of DNA recognition
14. Gene transcription by recruitment
15. The coregulator exchange in transcription functions of nuclear receptors
16. Co-activator and co-repressor complexes in nuclear receptor function
17. Chromatin unfolds
18. Transcription factors
19. A conserved DNA sequence in homeotic genes of the Drosophila, Antennapedia and Bithorax complexes
20. Homeodomain-DNA recognition
21. POU domain family values: Flexibility, partnership and developmental codes
22. A tissue specific transcription factor containing a homeodomain specifies a pituitary phenotype
23. Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas
24. Zinc proteins: Enzymes, storage proteins, transcription factors, and replication proteins
25. The transcriptional basis of steroid physiology
26. Do basic region-leucine zipper proteins bend their DNA targets ... Does it matter?
27. Mechanism of transcriptional regulation and neural gene expression
28. The regulation of AP-1 activity by mitogen-activated protein kinases
29. AP-1 function and regulation
30. DNA recognition by proteins with the helix-turn-helix motif
31. Function of the c-myc oncogenic transcription factor
32. Role of estrogen receptor-alpha in the anterior pituitary gland
33. In situ hybridization study of estrogen receptor messenger ribonucleic acid and in human adenohypophysial cells and pituitary adenomas
34. Haloperidol and estrogen induce c-myc and c-fos expression in the anterior pituitary gland of the rat
35. A novel target cell for c-fos induced in embryonic stem cell for c-fos induced oncogenesis: Development of chondrogenic tumors in embryonic stem cell cultures
36. c-myc, c-fos and c-myb gene expression in human pituitary tumors
37. Structure of Pit-1 POU-domain bound to DNA as a dimer: Unexpected arrangement and flexibility
38. Function of the homeodomain protein GHF-1 in pituitary cell proliferation
39. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1
40. A mutation in the POU-homeodomain of pit-1 responsible for combined pituitary hormone deficiency
41. Molecular basis of the little mouse phenotype and implications for cell type-specific growth
42. The tissue specific transcription factor Pit-1/GHF-1 binds to the c-fos serum response element and activates c-fos transcription
43. Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas
44. Pit-1/GHF-1 expression in pituitary adenomas: Further analogy between human adenomas and rat SMtTW tumors
45. Expression of Pit-1 and related proteins in diverse human pituitary adenomas
46. Molecular mechanism of action of steroid/thyroid receptor superfamily members
47. Multiple Pit-1-binding sites facilitate estrogen responsiveness of the prolactin gene
48. Ligand-independent recruitment of steroid receptor co-activators to estrogen receptor by cyclin D1
49. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response element
50. Enzyme-immunoassay for estrogen receptors in human pituitary adenomas
51. Estrogen receptors in human pituitary adenomas
52. Estrogen receptor expression in human pituitary: Correlation with immunohistochemistry and morphology in macroadenomas
53. Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells
54. Thyrotropin-releasing hormone increases the level of c-fos and β-actin mRNA in GH3/B6 pituitary tumor cells
55. Thyrotropin-releasing hormone stimulates in parallel jun B and c-fos messenger ribonucleic acids in GH3B6 pituitary cells: Comparison with PRL secretion
56. Classification and pathology of pituitary tumors
57. c-fos proto-oncogene regulation and function
58. Fos family members induce cell cycle entry by activating cyclin D1
59. Oncoprotein immunoreactivity in human pituitary tumors
60. Myc function and regulation
61. The retinoblastoma protein is linked to the activation of Ras
62. Interaction of c-myc with the pRb related protein p107 results in inhibition of c-myc mediated transactivation
63. Cell-cycle regulation of cdk2 activity by phosphorylation of Thr 160 and Tyr 15
64. Transforming growth factor beta (TGF-β) inhibits TGF alpha expression in bovine anterior pituitary derived cells
65. Inhibitory effect of the somatostatin analogue octreotide on rat pituitary tumor cell (GH3) proliferation in vitro
66. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue
67. Coordinate gene expression of luteinizing hormone-releasing hormone (LHRH) and the LHRH receptor after prolactin stimulation in the rat Nb2-T-cell line: Implication of a role in immunomodulation and cell cycle gene expression
68. Prolactin stimulates transcription of growth related genes in Nb2T-lymphoma cells
69. Sex differentiated deoxycholic and protein in rat liver carcinogenesis is under pituitary control
70. Expression of c-myc and c-fos proto-oncogene in the anterior pituitary gland of the rat: Effect of the estrogen
71. Expression of bcl-2 oncoprotein in pituitary tumors: Comparison with c-myc
72. Pituitary tumor transforming gene (PTTG) transforming and transactivation activity
73. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas
74. New pituitary oncogenes
75. A novel transcriptional activator (PO-B) binds between the TATA box and cap site of the pro-opiomelanocortin gene
76. Activation of the glycoprotein hormone alpha-subunit promoter by a LIM-homeodomain transcription factor
77. TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins